in

FibroGen, Inc. CEO & Chairman Thomas B. Neff Dead

Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive

SAN FRANCISCO, Aug. 26, 2019 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced today that Thomas B. Neff, Chief Executive Officer and Chairman of the Board of Directors of FibroGen, passed away unexpectedly this past weekend. Board member James A. Schoeneck has been named FibroGen’s Interim CEO.


Name: Thomas B. Neff

Country: USA

Company: FibroGen, Inc.

Branch: Pharma

Position: CEO & Chairman

Reason: Dead

Announcement Date: August 25, 2019, 10:00pm

Source 1: https://www.globenewswire.com/news-release/2019/08/26/1906483/0/en/Fibrogen-Announces-Passing-of-CEO-Thomas-B-Neff-Scientific-Innovator-and-Pioneering-Biopharmaceutical-Executive.html


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply